Oncology & Cancer

First-in-class targeted microRNA therapy slows cancer tumor growth

A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. As reported in Oncogene, tumors treated with the ...

Medications

Unlocking how the new Alzheimer's drug lecanemab works

Approved by the FDA earlier this year, the Alzheimer's therapy lecanemab is an antibody that reduces the buildup in the brain of a sticky peptide called amyloid-beta (Aβ), which is thought to be a main driver of the disease. ...

Arthritis & Rheumatism

Knee pain? Genicular artery embolization can offer relief

Of all the joints in the body, the knees get the most wear and tear. Decades of walking, running, sitting, jumping and other activities can take a toll on the cartilage—the smooth tissue between the bones—leading to osteoarthritis. ...

Medical research

Researchers find a chink in the armor of tuberculosis pathogen

Mycobacterium tuberculosis (Mtb) is the pathogen that causes tuberculosis (TB), the world's deadliest infectious disease. Mtb is so successful and harmful because it can adapt to different conditions inside our bodies, allowing ...

Diseases, Conditions, Syndromes

Mimicking the body's own defenses to destroy enveloped viruses

Just as bacteria can develop antibiotic resistance, viruses can also evade drug treatments. Developing therapies against these microbes is difficult because viruses often mutate or hide themselves within cells. But by mimicking ...

Medications

Research points to potential new medical therapy for Lyme disease

A medical therapy that inhibits the growth of cancer cells may one day be effective at treating Lyme disease, according to new research by a University of Massachusetts Amherst team at the New England Regional Center of Vector-borne ...

page 8 from 40